Clinical relevance of complement-fixing antibodies in cardiac transplantation.
نویسندگان
چکیده
This paper includes a review of the relative importance of pretransplant complement-fixing and non-complementing-fixing human leukocyte antigen (HLA) and non-HLA antibodies (Abs). Sera from 565 adult cardiac transplant recipients were retrospectively analysed for the presence of HLA antibodies using complement-dependent cytotoxicity (CDC), HLA-coated Luminex beads, and C4d deposition on Luminex beads and results were correlated with graft survival. Of 565 patients, 14 had CDC-positive donor-specific Abs (DSA) before their transplant. This number was increased by 53 using Luminex beads; of these, 19 had DSA by Luminex. Patients negative for CDC crossmatch, but Luminex positive with DSA demonstrated poor 1-year survival (42%) compared with 77% 1-year survival of patients with CDC-negative, Luminex positive non-donor-specific Abs. The effect of donor-specific Abs on allograft survival was further analyzed according to titer, immunoglobulin subclass, and ability to fix C4d onto Luminex beads. The ability to fix C4d, but not Ab titer or Ig subclass, was strongly associated with poor allograft survival (p = 0.0002). A retrospective analysis of sera from 616 cardiac transplant patients indicated the presence of immunoglobulin M complement-fixing non-HLA Abs was associated with early graft failure and a diagnosis of primary graft failure. In conclusion, complement-fixing Abs to relevant antigens are associated with poor allograft survival after heart transplantation.
منابع مشابه
Complement-fixing antibodies in cattle experimentally infected with Theileria annulata or vaccinated with tissue cultures
متن کامل
C4d fixing, luminex binding antibodies - a new tool for prediction of graft failure after heart transplantation.
The standard method to detect pretransplant antibodies has been the complement dependent cytotoxicity (CDC) test of donor leukocytes. Solid phase assays to detect HLA antibodies in pretransplant serum reveal a greater number of sensitized patients, but their clinical impact is less certain. Here we have developed a method of detecting C4d fixing HLA antibodies on Luminex beads. Pretransplant se...
متن کاملClinical relevance of pretransplant anti-HLA donor-specific antibodies: does C1q-fixation matter?
UNLABELLED Anti-HLA donor-specific antibodies (DSA) identified by single antigen bead array (SAB) are questioned for their excess in sensitivity and lack of event prediction after transplantation. POPULATION AND METHODS We retrospectively evaluated specific types of preformed DSA (class I, class II or C1q-fixing) and their impact on graft survival. Kidney transplantations performed across neg...
متن کاملA Case Study of Cryptococal Meningitis
A Case of Cryptococcal meningitis was diagnosed in a 22 year old Pigeon -fancier from Mazandaran prm ince of Iran (close to the Caspian sea). The patient was treated with systemic 5-nuoc to,;in and amphotericin B together with intrathecal injection of ampho. B. Further investigations showed an abnormal reduction in the number ofT-lymphocytes, while humoral immunity was maintained in the normal ...
متن کاملDetection of T and B cells specific complement-fixing alloantibodies using flow cytometry: A diagnostic approach for a resource limited laboratory
BACKGROUND AND OBJECTIVES Various methods have been reported for the detection of antibodies in recipient sera, which can be human leukocyte antigens (HLAs) or non-HLA specific, complement- or noncomplement fixing, as well as donor T (HLA-Class-I) and/or B cell (HLA-Class-I and II) specific. These alloantibodies play a pivotal role in antibody-mediated renal transplantation rejection. Depositio...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
عنوان ژورنال:
- Human immunology
دوره 70 8 شماره
صفحات -
تاریخ انتشار 2009